Alzheimer’s Research Papers
Shimizu-Okabe C, Yousef GM, Diamandis EP, Yoshida S, Shiosaka S, Fahnestock M. Expression of the kallikrein gene family in normal and Alzheimer's disease brain. Neuroreport. 2001 Aug 28;12(12):2747-51.
Yoshiyama Y, Arai K, Hattori T. Enhanced expression of I-kappaB with neurofibrillary pathology in Alzheimer's disease. Neuroreport. 2001 Aug 28;12(12):2641-5.
Ferrarese C, Aliprandi A, Tremolizzo L, Stanzani L, De Micheli A, Dolara A, Frattola L. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology. 2001 Aug 28;57(4):671-5.
Huang W, Alexander GE, Chang L, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Neurology. 2001 Aug 28;57(4):626-32.
Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E, Donepezil MSAD Study Investigators Group. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology. 2001 Aug 28;57(4):613-20.
Kallijärvi J, Haltia M, Baumann MH. Amphoterin includes a sequence motif which is homologous to the Alzheimer's beta-amyloid peptide (Abeta), forms amyloid fibrils in vitro, and binds avidly to Abeta. Biochemistry. 2001 Aug 28;40(34):10032-7.
Turner RT, Koelsch G, Hong L, Castanheira P, Ermolieff J, Ghosh AK, Tang J, Castenheira P, Ghosh A. Subsite specificity of memapsin 2 (beta-secretase): implications for inhibitor design. Biochemistry. 2001 Aug 28;40(34):10001-6.
Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J, Kilbridge JF, Carlson EJ, Epstein CJ, Mobley WC. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10439-44. ,
Haan J, Bakker E, Bornebroek M, Roos RA. [From gene to disease; amyloid-beta precursor protein gene instrumental in hereditary cerebral amyloid angiopathies] Ned Tijdschr Geneeskd. 2001 Aug 25;145(34):1639-41.
DeLorey TM, Lin RC, McBrady B, He X, Cook JM, Lameh J, Loew GH. Influence of benzodiazepine binding site ligands on fear-conditioned contextual memory. Eur J Pharmacol. 2001 Aug 24;426(1-2):45-54.
Cedazo-Mínguez A, Cowburn RF. Apolipoprotein E isoform-specific disruption of phosphoinositide hydrolysis: protection by estrogen and glutathione. FEBS Lett. 2001 Aug 24;504(1-2):45-9.
Götz J, Chen F, Van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 2001 Aug 24;293(5534):1491-5.
Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001 Aug 24;293(5534):1487-91. ,
Esler WP, Wolfe MS. A portrait of Alzheimer secretases--new features and familiar faces. Science. 2001 Aug 24;293(5534):1449-54.
Mori H, Motoi Y, Kobayashi T, Hasegawa M, Yamamura A, Iwatsubo T, Mizuno Y. Tau accumulation in a patient with pallidonigroluysian atrophy. Neurosci Lett. 2001 Aug 24;309(2):89-92.
Yip CM, Elton EA, Darabie AA, Morrison MR, McLaurin J. Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. J Mol Biol. 2001 Aug 24;311(4):723-34.
Bhojak TJ, DeKosky ST, Ganguli M, Kamboh MI. Genetic polymorphism in the cathepsin G gene and the risk of Alzheimer's disease. Neurosci Lett. 2001 Aug 24;309(2):138-40. ,
Hovatta O, Ahrlund-Richter L. [Ethical aspects of stem cell research. Legislation and guidelines in Europe] Lakartidningen. 2001 Aug 22;98(34):3515-9.
Riddell DR, Christie G, Hussain I, Dingwall C. Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr Biol. 2001 Aug 21;11(16):1288-93.
Narayanan V, Scarlata S. Membrane binding and self-association of alpha-synucleins. Biochemistry. 2001 Aug 21;40(33):9927-34.
Kirschenbaum F, Hsu SC, Cordell B, McCarthy JV. Glycogen synthase kinase-3beta regulates presenilin 1 C-terminal fragment levels. J Biol Chem. 2001 Aug 17;276(33):30701-7.
Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Mathis CA. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci. 2001 Aug 17;69(13):1471-84. ,
Kanski J, Drake J, Aksenova M, Engman L, Butterfield DA. Antioxidant activity of the organotellurium compound 3-[4-(N,N-dimethylamino)benzenetellurenyl]propanesulfonic acid against oxidative stress in synaptosomal membrane systems and neuronal cultures. Brain Res. 2001 Aug 17;911(1):12-21.
Harris IM, Harris JA, Caine D. Object orientation agnosia: a failure to find the axis? J Cogn Neurosci. 2001 Aug 15;13(6):800-12.
Ponting CP. Domain homologues of dopamine beta-hydroxylase and ferric reductase: roles for iron metabolism in neurodegenerative disorders? Hum Mol Genet. 2001 Aug 15;10(17):1853-8.
Bowen RL. Sex hormones, amyloid protein, and Alzheimer disease. JAMA. 2001 Aug 15;286(7):790-1.
Winterle JS, Mill T, Harris T, Goldbeck RA. Absolute kinetic characterization of 17-beta-estradiol as a radical-scavenging, antioxidant synergist. Arch Biochem Biophys. 2001 Aug 15;392(2):233-44.
Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB. In-vivo measurement of activated microglia in dementia. Lancet. 2001 Aug 11;358(9280):461-7.
van Gool WA, Weinstein HC, Scheltens P, Walstra GJ, Scheltens PK. Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study. Lancet. 2001 Aug 11;358(9280):455-60.
Jones RW. Inflammation and Alzheimer's disease. Lancet. 2001 Aug 11;358(9280):436-7.
Trabace L, Cassano T, Cagiano R, Tattoli M, Pietra C, Steardo L, Kendrick KM, Cuomo V. Effects of ENA713 and CHF2819, two anti-Alzheimer's disease drugs, on rat amino acid levels. Brain Res. 2001 Aug 10;910(1-2):182-6.
Berezovska O, Jack C, Deng A, Gastineau N, Rebeck GW, Hyman BT. Notch1 and amyloid precursor protein are competitive substrates for presenilin1-dependent gamma-secretase cleavage. J Biol Chem. 2001 Aug 10;276(32):30018-23.
Mitrasinovic OM, Perez GV, Zhao F, Lee YL, Poon C, Murphy GM. Overexpression of macrophage colony-stimulating factor receptor on microglial cells induces an inflammatory response. J Biol Chem. 2001 Aug 10;276(32):30142-9.
McIlroy SP, Dynan KB, Vahidassr DJ, Lawson JT, Patterson CC, Passmore P. Common polymorphisms in LRP and A2M do not affect genetic risk for Alzheimer disease in Northern Ireland. Am J Med Genet. 2001 Aug 8;105(6):502-6. , ,
Hasegawa H, Nakai M, Tanimukai S, Taniguchi T, Terashima A, Kawamata T, Fukunaga K, Miyamoto E, Misaki K, Mukai H, Tanaka C. Microglial signaling by amyloid beta protein through mitogen-activated protein kinase mediating phosphorylation of MARCKS. Neuroreport. 2001 Aug 8;12(11):2567-71.
Milton NG, Mayor NP, Rawlinson J. Identification of amyloid-beta binding sites using an antisense peptide approach. Neuroreport. 2001 Aug 8;12(11):2561-6.
Botta L, Valli P, Asti A, Perin P, Zucca G, Racchi M, Govoni S, Pascale A. beta amyloid-induced disruption of ionic balance: studies on the isolated frog labyrinth. Neuroreport. 2001 Aug 8;12(11):2493-7.
Fukuhara R, Ikeda M, Nebu A, Kikuchi T, Maki N, Hokoishi K, Shigenobu K, Komori K, Tanabe H. Alteration of rCBF in Alzheimer's disease patients with delusions of theft. Neuroreport. 2001 Aug 8;12(11):2473-6.
Gonzalez-Lima F, Berndt JD, Valla JE, Games D, Reiman EM. Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease. Neuroreport. 2001 Aug 8;12(11):2375-9.
Catani M, Cherubini A, Howard R, Tarducci R, Pelliccioli GP, Piccirilli M, Gobbi G, Senin U, Mecocci P. (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. Neuroreport. 2001 Aug 8;12(11):2315-7.
Santiard-Baron D, Lacoste A, Ellouk-Achard S, Soulié C, Nicole A, Sarasin A, Ceballos-Picot I. The amyloid peptide induces early genotoxic damage in human preneuron NT2. Mutat Res. 2001 Aug 8;479(1-2):113-20.
Soriano S, Lu DC, Chandra S, Pietrzik CU, Koo EH. The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases. J Biol Chem. 2001 Aug 3;276(31):29045-50.
Miserez AR. [Alzheimer dementia--a disorder of lipoprotein metabolism?] Schweiz Rundsch Med Prax. 2001 Aug 2;90(31-32):1297-9.
Burkman RT, Collins JA, Greene RA. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol. 2001 Aug;185(2 Suppl):S13-23.
Rice DP, Fillit HM, Max W, Knopman DS, Lloyd JR, Duttagupta S. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective. Am J Manag Care. 2001 Aug;7(8):809-18.
Nobili F, Vitali P, Calvini P, Bollati F, Girtler N, Delmonte M, Mariani G, Rodriguez G. Clinical correlative evaluation of an iterative method for reconstruction of brain SPECT images. Nucl Med Biol. 2001 Aug;28(6):627-32.
Lampley-Dallas VT. Medications for the treatment of Alzheimer's disease. J Okla State Med Assoc. 2001 Aug;94(8):347-9.
Chung HY, Choi HR, Park HJ, Choi JS, Choi WC. Peroxynitrite scavenging and cytoprotective activity of 2,3,6-tribromo-4,5-dihydroxybenzyl methyl ether from the marine alga Symphyocladia latiuscula. J Agric Food Chem. 2001 Aug;49(8):3614-21.
Brandt R. Cytoskeletal mechanisms of neuronal degeneration. Cell Tissue Res. 2001 Aug;305(2):255-65.
Liu DX, Greene LA. Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res. 2001 Aug;305(2):217-28.
Hobson JP, Coyle JM, Leeds L, Meara RJ. Health professionals knowledge about Alzheimer's disease. Int J Geriatr Psychiatry. 2001 Aug;16(8):822-3.
Polo-Kantola P, Erkkola R. Alzheimer's disease and estrogen replacement therapy--where are we now? Acta Obstet Gynecol Scand. 2001 Aug;80(8):679-82.
Marshall MJ, Hutchinson SA. A critique of research on the use of activities with persons with Alzheimer's disease: a systematic literature review. J Adv Nurs. 2001 Aug;35(4):488-96.
Manthey D, Heck S, Engert S, Behl C. Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. Eur J Biochem. 2001 Aug;268(15):4285-91.
Sakaguchi M, Miyazaki M, Kondo T, Namba M. Up-regulation of S100C in normal human fibroblasts in the process of aging in vitro. Exp Gerontol. 2001 Aug;36(8):1317-25.
Joosten E. Homocysteine, vascular dementia and Alzheimer's disease. Clin Chem Lab Med. 2001 Aug;39(8):717-20.
Tsuchiya K, Mitani K, Arai T, Yamada S, Komiya T, Esaki Y, Haga C, Yamanouchi H, Ikeda K. Argyrophilic grain disease mimicking temporal Pick's disease: a clinical, radiological, and pathological study of an autopsy case with a clinical course of 15 years. Acta Neuropathol (Berl). 2001 Aug;102(2):195-9.
Sugarman J, Cain C, Wallace R, Welsh-Bohmer KA. How proxies make decisions about research for patients with Alzheimer's disease. J Am Geriatr Soc. 2001 Aug;49(8):1110-9.
Karlawish JH, Casarett D, Klocinski J, Clark CM. The relationship between caregivers' global ratings of Alzheimer's disease patients' quality of life, disease severity, and the caregiving experience. J Am Geriatr Soc. 2001 Aug;49(8):1066-70.
Lee BF, Liu CK, Tai CT, Chiu NT, Liu GC, Yu HS, Pai MC. Alzheimer's disease: scintigraphic appearance of Tc-99m HMPAO brain SPECT. Kaohsiung J Med Sci. 2001 Aug;17(8):394-400.
Galván M, David JP, Delacourte A, Luna J, Mena R. Sequence of neurofibrillary changes in aging and Alzheimer's disease: A confocal study with phospho-tau antibody, AD2. J Alzheimers Dis. 2001 Aug;3(4):417-425.
Velez-Pardo C, Arroyave ST, Lopera F, Castaño AD, Jimenez Del Rio M. Ultrastructure evidence of necrotic neural cell death in familial Alzheimer's disease brains bearing presenilin-1 E280A mutation. J Alzheimers Dis. 2001 Aug;3(4):409-415.
Luo Y. Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease. J Alzheimers Dis. 2001 Aug;3(4):401-407.
Figueroa DJ, Shi XP, Gardell SJ, Austin CP. Abetapp secretases are co-expressed with Abetapp in the pancreatic islets. J Alzheimers Dis. 2001 Aug;3(4):393-396.
Ghribi O, DeWitt DA, Forbes MS, Arad A, Herman MM, Savory J. Cyclosporin A inhibits Al-induced cytochrome c release from mitochondria in aged rabbits. J Alzheimers Dis. 2001 Aug;3(4):387-391.
Ranganathan S, Scudiere S, Bowser R. Hyperphosphorylation of the retinoblastoma gene product and altered subcellular distribution of E2F-1 during Alzheimer's disease and amyotrophic lateral sclerosis. J Alzheimers Dis. 2001 Aug;3(4):377-385.
Hughes LF, Struble RG, Shaffer CL. Olfaction in elderly and patients with Alzheimer's disease: Differing feedback conditions. J Alzheimers Dis. 2001 Aug;3(4):367-375.
Stone TW, Behan WM, Jones PA, Darlington LG, Smith RA. The role of kynurenines in the production of neuronal death, and the neuroprotective effect of purines. J Alzheimers Dis. 2001 Aug;3(4):355-366.
Santiago Grisoli;a J. Stem Cell Grafting for Epilepsy: Clinical Promise and Ethical Concerns. . 2001 Aug;2(4):318-323.
Giovannetti T, Lamar M, Cloud BS, Swenson R, Fein D, Kaplan E, Libon DJ. Different underlying mechanisms for deficits in concept formation in dementia. Arch Clin Neuropsychol. 2001 Aug;16(6):547-60.
Zhu H, Yu J, Kindy MS. Inhibition of amyloidosis using low-molecular-weight heparins. Mol Med. 2001 Aug;7(8):517-22.
Grinstead K, Rusted J. Do people with Alzheimer's disease have a disproportionate deficit in functional knowledge? Verbal versus motoric access to semantic memory. Aging Ment Health. 2001 Aug;5(3):295-300.
Janus C, Westaway D. Transgenic mouse models of Alzheimer's disease. Physiol Behav. 2001 Aug;73(5):873-86.
Mattila PM, Röyttä M, Lönnberg P, Marjamäki P, Helenius H, Rinne JO. Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment. Acta Neuropathol (Berl). 2001 Aug;102(2):160-6.
Ferrer I, Puig B, Krupinsk J, Carmona M, Blanco R. Fas and Fas ligand expression in Alzheimer's disease. Acta Neuropathol (Berl). 2001 Aug;102(2):121-31.
Qiao X, Cummins DJ, Paul SM. Neuroinflammation-induced acceleration of amyloid deposition in the APPV717F transgenic mouse. Eur J Neurosci. 2001 Aug;14(3):474-82.
Radau PE, Slomka PJ, Julin P, Svensson L, Wahlund LO. Evaluation of linear registration algorithms for brain SPECT and the errors due to hypoperfusion lesions. Med Phys. 2001 Aug;28(8):1660-8.
Bridi R, Crossetti FP, Steffen VM, Henriques AT. The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats. Phytother Res. 2001 Aug;15(5):449-51.
Connor LT, Obler LK, Tocco M, Fitzpatrick PM, Albert ML. Effect of socioeconomic status on aphasia severity and recovery. Brain Lang. 2001 Aug;78(2):254-7.
Choi SH, Park CH, Koo JW, Seo JH, Kim HS, Jeong SJ, Lee JH, Kim SS, Suh YH. Memory impairment and cholinergic dysfunction by centrally administered Abeta and carboxyl-terminal fragment of Alzheimer's APP in mice. FASEB J. 2001 Aug;15(10):1816-8.
Post SG. Preventing schizophrenia and Alzheimer disease: comparative ethics. Schizophr Res. 2001 Aug 1;51(1):103-8.
Armstrong RA, Lantos PL, Cairns NJ. The spatial patterns of pathological brain lesions in 12 patients with corticobasal degeneration. Pathophysiology. 2001 Aug;8(1):47-53.
DeVane CL, Nemeroff CB. An evaluation of risperidone drug interactions. J Clin Psychopharmacol. 2001 Aug;21(4):408-16.
Nizetic D. Functional genomics of the Down syndrome. Croat Med J. 2001 Aug;42(4):421-7.
Elsner RJ. Odor threshold, recognition, discrimination and identification in centenarians. Arch Gerontol Geriatr. 2001 Aug;33(1):81-94.
Yu PH. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia. Med Hypotheses. 2001 Aug;57(2):175-9.
Maurizi CP. Alzheimer's disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal fluid deficiency of melatonin. Med Hypotheses. 2001 Aug;57(2):156-60.
Allison AC. The possible role of vitamin K deficiency in the pathogenesis of Alzheimer's disease and in augmenting brain damage associated with cardiovascular disease. Med Hypotheses. 2001 Aug;57(2):151-5.
Parkkinen L, Soininen H, Laakso M, Alafuzoff I. Alpha-synuclein pathology is highly dependent on the case selection. Neuropathol Appl Neurobiol. 2001 Aug;27(4):314-25.
Rhodin JA, Thomas T. A vascular connection to Alzheimer's disease. Microcirculation. 2001 Aug;8(4):207-20.
Mungas D, Reed BR, Ellis WG, Jagust WJ. The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Arch Neurol. 2001 Aug;58(8):1243-7.
Lipton AM, Cullum CM, Satumtira S, Sontag E, Hynan LS, White CL, Bigio EH. Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias. Arch Neurol. 2001 Aug;58(8):1233-9.
Almeida OP, Waterreus A, Spry N, Corica T, Martins G, Martins RN, Flicker L. Effect of testosterone deprivation on the cognitive performance of a patient with Alzheimer's disease. Int J Geriatr Psychiatry. 2001 Aug;16(8):823-5.
Ueki A, Shinjo H, Shimode H, Nakajima T, Morita Y. Factors associated with mortality in patients with early-onset Alzheimer's disease: a five-year longitudinal study. Int J Geriatr Psychiatry. 2001 Aug;16(8):810-5.
De Vreese LP, Neri M, Fioravanti M, Belloi L, Zanetti O. Memory rehabilitation in Alzheimer's disease: a review of progress. Int J Geriatr Psychiatry. 2001 Aug;16(8):794-809.
Saunders AM. Gene identification in Alzheimer's disease. Pharmacogenomics. 2001 Aug;2(3):239-49.
Kim JH, Kim SI, Song KS. Prolyl endopeptidase inhibitors from green tea. Arch Pharm Res. 2001 Aug;24(4):292-6.
Dierssen M, Fillat C, Crnic L, Arbonés M, Flórez J, Estivill X. Murine models for Down syndrome. Physiol Behav. 2001 Aug;73(5):859-71.
Tomidokoro Y, Harigaya Y, Matsubara E, Ikeda M, Kawarabayashi T, Shirao T, Ishiguro K, Okamoto K, Younkin SG, Shoji M. Brain Abeta amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau. J Pathol. 2001 Aug;194(4):500-6.
Huang Y, Wang KK. The calpain family and human disease. Trends Mol Med. 2001 Aug;7(8):355-62.
Fahnestock M, Michalski B, Xu B, Coughlin MD. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci. 2001 Aug 1;18(2):210-20.
Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol. 2001 Aug 1;64(6):575-611.
Lee BF, Liu CK, Tai CT, Chiu NT, Liu GC, Yu HS, Pai MC. Alzheimer's disease: scintigraphic appearance of Tc-99m HMPAO brain spect. Kaohsiung J Med Sci. 2001 Aug;17(8):394-400.
Wijk H, Sivik L, Steen B, Berg S. Color and form as support for picture recognition in old age. Aging (Milano). 2001 Aug;13(4):298-308.
Osoegawa M, Takao T, Taniwaki T, Kikuchi H, Arakawa K, Furuya H, Iwaki T, Kira J. [An autopsy case of dementia with motor neuron disease accompanying Alzheimer's disease lesion] Rinsho Shinkeigaku. 2001 Aug;41(8):482-6.
Langley LK, Fuentes LJ, Hochhalter AK, Brandt J, Overmier JB. Inhibition of return in aging and Alzheimer's disease: performance as a function of task demands and stimulus timing. J Clin Exp Neuropsychol. 2001 Aug;23(4):431-46.
Andrikopoulos J. Malingering disorientation to time, personal information, and place in mild head injured litigants. Clin Neuropsychol. 2001 Aug;15(3):393-6.
Kontush A. Alzheimer's amyloid-beta as a preventive antioxidant for brain lipoproteins. Cell Mol Neurobiol. 2001 Aug;21(4):299-315.
Surguchov A, Palazzo RE, Surgucheva I. Gamma synuclein: subcellular localization in neuronal and non-neuronal cells and effect on signal transduction. Cell Motil Cytoskeleton. 2001 Aug;49(4):218-28.
Heath AW. Recent advances in vaccinology. Curr Opin Pharmacol. 2001 Aug;1(4):425-30.
Loeffler DA, Sima AA, LeWitt PA. Ceruloplasmin immunoreactivity in neurodegenerative disorders. Free Radic Res. 2001 Aug;35(2):111-8.
Gil N, Josman N. Memory and metamemory performance in Alzheimer's disease and healthy elderly: the Contextual Memory Test (CMT). Aging (Milano). 2001 Aug;13(4):309-15.
Schneider LS. Assessing outcomes in Alzheimer disease. Alzheimer Dis Assoc Disord. 2001 Aug;15 Suppl 1:S8-18.
Winblad B. Maintaining functional and behavioral abilities in Alzheimer disease. Alzheimer Dis Assoc Disord. 2001 Aug;15 Suppl 1:S34-40.
DeKosky ST, Orgogozo JM. Alzheimer disease: diagnosis, costs, and dimensions of treatment. Alzheimer Dis Assoc Disord. 2001 Aug;15 Suppl 1:S3-7.
Tariot PN. Maintaining cognitive function in Alzheimer disease: how effective are current treatments? Alzheimer Dis Assoc Disord. 2001 Aug;15 Suppl 1:S26-33.
Albuquerque EX, Santos MD, Alkondon M, Pereira EF, Maelicke A. Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease. Alzheimer Dis Assoc Disord. 2001 Aug;15 Suppl 1:S19-25.
Morishima-Kawashima M, Saido TC, Ihara Y. [Alzheimer's disease and the proteins] Tanpakushitsu Kakusan Koso. 2001 Aug;46(11 Suppl):1798-804.
Mcpherson A, Furniss FG, Sdogati C, Cesaroni F, Tartaglini B, Lindesay J. Effects of individualized memory aids on the conversation of persons with severe dementia: a pilot study. Aging Ment Health. 2001 Aug;5(3):289-94.
Pekkonen E, Hirvonen J, Jääskeläinen IP, Kaakkola S, Huttunen J. Auditory sensory memory and the cholinergic system: implications for Alzheimer's disease. Neuroimage. 2001 Aug;14(2):376-82.
Baron JC, Chételat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, Eustache F. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage. 2001 Aug;14(2):298-309.
Stéphan A, Laroche S, Davis S. Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci. 2001 Aug 1;21(15):5703-14.
Massi F, Straub JE. Probing the origins of increased activity of the E22Q "Dutch" mutant Alzheimer's beta-amyloid peptide. Biophys J. 2001 Aug;81(2):697-709.
Slack BE, Ma LK, Seah CC. Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme. Biochem J. 2001 Aug 1;357(Pt 3):787-94.
Eidenmüller J, Fath T, Maas T, Pool M, Sontag E, Brandt R. Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. Biochem J. 2001 Aug 1;357(Pt 3):759-67.
Kontush A, Mann U, Arlt S, Ujeyl A, Lührs C, Müller-Thomsen T, Beisiegel U. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. Free Radic Biol Med. 2001 Aug 1;31(3):345-54.
Andorn AC, Pappolla MA. Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brain. Free Radic Biol Med. 2001 Aug 1;31(3):315-20.
Pasinetti GM. Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia. Arch Gerontol Geriatr. 2001 Aug;33(1):13-28.
Giffard B, Desgranges B, Nore-Mary F, Lalevée C, de la Sayette V, Pasquier F, Eustache F. The nature of semantic memory deficits in Alzheimer's disease: new insights from hyperpriming effects. Brain. 2001 Aug;124(Pt 8):1522-32.
Baddeley AD, Baddeley HA, Bucks RS, Wilcock GK. Attentional control in Alzheimer's disease. Brain. 2001 Aug;124(Pt 8):1492-508.
Sala SD, Logie RH. Theoretical and practical implications of dual-task performance in Alzheimer's disease. Brain. 2001 Aug;124(Pt 8):1479-81.
Liepert J, Bär KJ, Meske U, Weiller C. Motor cortex disinhibition in Alzheimer's disease. Clin Neurophysiol. 2001 Aug;112(8):1436-41.
Petrosian AA, Prokhorov DV, Lajara-Nanson W, Schiffer RB. Recurrent neural network-based approach for early recognition of Alzheimer's disease in EEG. Clin Neurophysiol. 2001 Aug;112(8):1378-87.
van Amelsvoort T, Compton J, Murphy D. In vivo assessment of the effects of estrogen on human brain. Trends Endocrinol Metab. 2001 Aug;12(6):273-6.
Liu HC, Hong CJ, Liu CY, Lin KN, Tsai SJ, Liu TY, Chi CW, Wang PN. Association analysis of the 5-HT6 receptor polymorphism C267T with depression in patients with Alzheimer's disease. Psychiatry Clin Neurosci. 2001 Aug;55(4):427-9. ,
Woo SI, Kim JW, Seo HG, Park CH, Han SH, Kim SH, Kim KW, Jhoo JH, Woo JI. CYP2D6*4 polymorphism is not associated with Parkinson's disease and has no protective role against Alzheimer's disease in the Korean population. Psychiatry Clin Neurosci. 2001 Aug;55(4):373-7. ,
Saito H, Yamazaki H, Matsuoka H, Matsumoto K, Numachi Y, Yoshida S, Ueno T, Sato M. Visual event-related potential in mild dementia of the Alzheimer's type. Psychiatry Clin Neurosci. 2001 Aug;55(4):365-71.
Pocernich CB, Cardin AL, Racine CL, Lauderback CM, Butterfield DA. Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease. Neurochem Int. 2001 Aug;39(2):141-9.
Mattson MP, Chan SL, Camandola S. Presenilin mutations and calcium signaling defects in the nervous and immune systems. Bioessays. 2001 Aug 1;23(8):733-44.
Müller WE, Kirsch C, Eckert GP. Membrane-disordering effects of beta-amyloid peptides. Biochem Soc Trans. 2001 Aug;29(Pt 4):617-23.
Johansson J. Membrane properties and amyloid fibril formation of lung surfactant protein C. Biochem Soc Trans. 2001 Aug;29(Pt 4):601-6.
Steiner H, Winkler E, Shearman MS, Prywes R, Haass C. Endoproteolysis of the ER stress transducer ATF6 in the presence of functionally inactive presenilins. Neurobiol Dis. 2001 Aug;8(4):717-22.
Steinhoff T, Moritz E, Wollmer MA, Mohajeri MH, Kins S, Nitsch RM. Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques. Neurobiol Dis. 2001 Aug;8(4):647-54.
White F, Nicoll JA, Roses AD, Horsburgh K. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol Dis. 2001 Aug;8(4):611-25.
Poduslo JF, Curran GL, Wengenack TM, Malester B, Duff K. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease. Neurobiol Dis. 2001 Aug;8(4):555-67.
Ruitenberg A, Kalmijn S, de Ridder MA, Redekop WK, van Harskamp F, Hofman A, Launer LJ, Breteler MM. Prognosis of Alzheimer's disease: the Rotterdam Study. Neuroepidemiology. 2001 Aug;20(3):188-95.
Casadei VM, Ferri C, Calabrese E, Grimaldi LM, Franceschi M, Veglia F, Licastro F, Mariani C. Prion protein gene polymorphism and Alzheimer's disease: one modulatory trait of cognitive decline? J Neurol Neurosurg Psychiatry. 2001 Aug;71(2):279-80. ,
De Jonghe C, Esselens C, Kumar-Singh S, Craessaerts K, Serneels S, Checler F, Annaert W, Van Broeckhoven C, De Strooper B. Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum Mol Genet. 2001 Aug 1;10(16):1665-71.
Law A, Gauthier S, Quirion R. Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity. Br J Pharmacol. 2001 Aug;133(7):1114-24.
Mori T, Paris D, Town T, Rojiani AM, Sparks DL, Delledonne A, Crawford F, Abdullah LI, Humphrey JA, Dickson DW, Mullan MJ. Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice. J Neuropathol Exp Neurol. 2001 Aug;60(8):778-85.
Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 2001 Aug;60(8):759-67.
Le R, Cruz L, Urbanc B, Knowles RB, Hsiao-Ashe K, Duff K, Irizarry MC, Stanley HE, Hyman BT. Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption. J Neuropathol Exp Neurol. 2001 Aug;60(8):753-8.
Sigurdsson EM, Scholtzova H, Mehta PD, Frangione B, Wisniewski T. Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am J Pathol. 2001 Aug;159(2):439-47.
Shi J, Ma C, Lao H, Feng R, Guo Y, Mu N, Li Q, Tan Y, Wang D. [No evidence for association between the alpha 2-macroglobulin polymorphism and Alzheimer's disease in the Han Chinese] Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001 Aug;18(4):299-302.
Small DH, Mok SS, Bornstein JC. Alzheimer's disease and Abeta toxicity: from top to bottom. Nat Rev Neurosci. 2001 Aug 1;2(8):595-8.
Chen F, Yu G, Arawaka S, Nishimura M, Kawarai T, Yu H, Tandon A, Supala A, Song YQ, Rogaeva E, Milman P, Sato C, Yu C, Janus C, Lee J, Song L, Zhang L, Fraser PE, St George-Hyslop PH. Nicastrin binds to membrane-tethered Notch. Nat Cell Biol. 2001 Aug;3(8):751-4.
No comments:
Post a Comment